CONDENSED INTERIM STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
|
3 Months Ended |
Nov. 30, 2021 |
Nov. 30, 2020 |
| Cash flows used in operating activities |
|
|
| Net Income (loss) |
$ (116,219)
|
$ 222,603
|
| Changes to reconcile net loss to net cash used in operating activities |
|
|
| Shares issued for exploration cost |
0
|
0
|
| Stock based compensation |
23,056
|
15,450
|
| Income from Royalty grant |
0
|
(250,000)
|
| Unrealized gain on marketable securities |
(449)
|
(16,250)
|
| Gain on disposal of marketable securities |
0
|
(894)
|
| Interest on loan payable |
0
|
0
|
| Change in non-cash working capital items: |
|
|
| Accounts receivable |
(1,516)
|
(810)
|
| Prepaid expenses and deposit |
11,107
|
(7,718)
|
| Accounts payable and accrued liabilities |
(20,225)
|
2,547
|
| Due to related parties |
(21,000)
|
(5,250)
|
| Net cash (used in) operating activities |
(125,246)
|
(40,322)
|
| Cash flows from Investing activities |
|
|
| Proceeds from disposal of marketable securities |
0
|
2,069
|
| Proceeds from royalty grant |
0
|
250,000
|
| Net cash from investing activities |
0
|
252,069
|
| Cash flows from (used in) Financing activities |
|
|
| Proceeds from warrant exercise |
131,390
|
0
|
| Net cash from (used in) Financing activities |
131,390
|
0
|
| Increase (Decrease) in cash and cash equivalents |
6,144
|
211,747
|
| Cash and cash equivalents, beginning of period |
354,286
|
45,528
|
| Cash and cash equivalents, end of period |
360,430
|
257,275
|
| Supplemental information of cash flows |
|
|
| Interest paid in cash |
0
|
0
|
| Income taxes paid in cash |
$ 0
|
$ 0
|